Exosomal miR ‐142‐3p from M1 ‐polarized macrophages suppresses cell growth and immune escape in glioblastoma through regulating HMGB1 ‐mediated PD ‐1/ PD ‐ L1 checkpoint
Journal of Neurochemistry · 2025
DOI: 10.1111/jnc.16224 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurochemistry, 2025. Verfasst von Yigong Wei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Glioblastoma, MicroRNAs, HMGB1 Protein, Exosomes. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Glioblastoma (GBM) is one of the most prevalent cancerous brain tumors. Former studies have reported that exosomes derived from M1‐polarized macrophages (M1 exosomes) inhibit tumor occurrence and development through delivery of tumor suppressor genes. Also, microRNA‐142‐3p (miR‐142‐3p) has been verified to function as a tumor suppressor. GBM cell proliferation was evaluated by Cell Counting Kit‐8 (CCK‐8), colony formation assay and 5‐ethynyl‐2′‐deoxyuridine (EdU) assay; cell apoptosis was determined by flow cytometry analysis and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. Mechanism investigations were conducted for analyzing the molecular mechanism by which miR‐142‐3p and M1 exosomes affect GBM progression. Upregulation of miR‐142‐3p expression was detected in M1‐polarized macrophages and M1 exosomes. M1 exosomes inhibit GBM cell proliferation and trigger cell apoptosis. Functionally, miR‐142‐3p silencing promotes the proliferation and inhibits the apoptosis of GBM cells treated with M1 exosomes. As for molecular mechanism, miR‐142‐3p inhibits GBM cell growth via targeting high‐mobility group box 1 (HMGB1). In addition, miR‐142‐3p/HMGB1 axis affects GBM cell immune escape through modulation of programmed death‐1/programmed death ligand‐1 (PD‐1/PD‐L1) checkpoint. Our study demonstrated that exosomal miR‐142‐3p from M1‐polarized macrophages suppresses cell growth and immune escape in GBM through regulating HMGB1‐mediated PD‐1/PD‐L1 checkpoint. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, China.
- Department of Neurosurgery, Jinyang Hospital Affiliated to Guizhou Medical University (Guiyang Second People's Hospital), Guiyang, China.
- Department of Neurosurgery, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
ORCID-Profile: Xuhui Hui
Zitieren
APA
Wei, Y., Zhou, K., Wang, C., Du, X., Wang, Z., Chen, G., Zhang, H., & Hui, X. (2025). Exosomal miR ‐142‐3p from M1 ‐polarized macrophages suppresses cell growth and immune escape in glioblastoma through regulating HMGB1 ‐mediated PD ‐1/ PD ‐ L1 checkpoint. Journal of Neurochemistry. https://doi.org/10.1111/jnc.16224
Vancouver
Wei Y, Zhou K, Wang C, Du X, Wang Z, Chen G, et al. Exosomal miR ‐142‐3p from M1 ‐polarized macrophages suppresses cell growth and immune escape in glioblastoma through regulating HMGB1 ‐mediated PD ‐1/ PD ‐ L1 checkpoint. Journal of Neurochemistry. 2025. doi:10.1111/jnc.16224
BibTeX
@article{Wei2025,
author = {Wei, Yigong and Zhou, Kun and Wang, Cheng and Du, Xiaolin and Wang, Zhengdi and Chen, Guangtang and Zhang, Huan and Hui, Xuhui},
title = {Exosomal miR ‐142‐3p from M1 ‐polarized macrophages suppresses cell growth and immune escape in glioblastoma through regulating HMGB1 ‐mediated PD ‐1/ PD ‐ L1 checkpoint},
journal = {Journal of Neurochemistry},
year = {2025},
doi = {10.1111/jnc.16224}
}
EUVIMED